Clinical trial

Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers

NCT02774759

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Accelerometer Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Questionnaires Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Fitness Test Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Resistance Training Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Aerobic Exercise Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Telephone Coaching/Phone Calls Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Video Chat Sessions Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-10-17

PhaseNA

Conditions

Malignant Neoplasms of Female Genital Organsunresolved

Interventions

AccelerometerDEVICE

QuestionnairesBEHAVIORAL

Fitness TestBEHAVIORAL

Resistance TrainingBEHAVIORAL

Aerobic ExerciseBEHAVIORAL

Telephone Coaching/Phone CallsBEHAVIORAL

Video Chat SessionsBEHAVIORAL

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02774759 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.